• BRIEF-Abbvie, Harbour Biomed, Utrecht University And Erasmus Medical Center Collaborate To Develop Covid-19 Antibody Therapy

    • June 8, 2020
    • Posted By : admin
    • 0 Comment
    •   128 views

    ABBVIE, HARBOUR BIOMED, UTRECHT UNIVERSITY AND ERASMUS MEDICAL CENTER ANNOUNCE COLLABORATION TO DEVELOP MONOCLONAL ANTIBODY THERAPY TO PREVENT AND TREAT COVID-19

    * ABBVIE INC – CO, HBM, UU AND EMC ANNOUNCED THEY HAVE ENTERED COLLABORATION TO DEVELOP A NOVEL ANTIBODY THERAPEUTIC TO PREVENT AND TREAT COVID-19

    ABBVIE – TO SUPPORT UU, EMC, HBM THROUGH PRECLINICAL ACTIVITIES, WHILE UNDERTAKING PREPARATIONS FOR LATER STAGE PRECLINICAL, CLINICAL DEVELOPMENT WORK

    * ABBVIE INC – TO GET OPTION TO EXCLUSIVELY LICENSE ANTIBODY FROM THREE PARTIES FOR THERAPEUTIC CLINICAL DEVELOPMENT, COMMERCIALIZATION WORLDWIDE

    0Shares
  128 views

You Might Also Like

No comments found

LEAVE COMMENT

Archive

Offers